Literature DB >> 7174792

Marfan syndrome. Demonstration of abnormal elastin in aorta.

P A Abraham, A J Perejda, W H Carnes, J Uitto.   

Abstract

Aortae from three patients with classic presentation of Marfan syndrome, who died of vascular complications, were subjected to biochemical analyses of the connective tissue; for comparison, aortae from eight age-matched controls, without evidence of connective tissue abnormalities, were examined. Elastin was prepared from the aortae by two techniques. First, the tissues were extracted with 5 M guanidine-HCl, bacterial collagenase digestion and reduction with dithiothreitol (elastin I preparation). Secondly, this material was further purified by extraction with 0.1 M NaOH at 99 degrees C (elastin II preparation). Amino acid analyses of both elastin preparations indicated that the values for desmosine and isodesmosine were reduced in Marfan cases to approximately one-half of the control values. A corresponding increase in lysyl residues was noted in elastin II preparations. Also, the concentration of elastin per milligram dry weight of tissue was reduced in Marfan cases. The hydroxyproline content of elastin was increased in two cases with the Marfan syndrome. Recoveries indicated that the alkali treatment solubilized 46.2% of the elastin I preparations in Marfan aortae compared with 23.7% in controls. In contrast to elastin, the concentration and solubility of collagen were unchanged; the amino acid composition and the genetic types of insoluble collagen isolated by limited pepsin proteolysis were the same in both Marfan and control aortae. The results of our study demonstrate that the cross-linking of aortic elastin is reduced in the three patients with Marfan syndrome. Thus, a defect in elastin could explain the vascular fragility observed clinically in these patients.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7174792      PMCID: PMC370341          DOI: 10.1172/jci110723

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  Application of affinity chromatography to the purification of collagenase for the isolation of insoluble elastin.

Authors:  A Serafini-Fracassini; J M Field; G W Rodger; M Spina
Journal:  Biochim Biophys Acta       Date:  1975-03-28

2.  Modifications of a specific assay for hydroxyproline in urine.

Authors:  K I Kivirikko; O Laitinen; D J Prockop
Journal:  Anal Biochem       Date:  1967-05       Impact factor: 3.365

3.  Letter: Collagen of Marfan syndrome is abnormally soluble.

Authors:  R E Priest; J F Moinuddin; J H Priest
Journal:  Nature       Date:  1973-10-05       Impact factor: 49.962

4.  The production of lysyl oxidase by human fibroblasts in culture.

Authors:  D L Layman; A S Narayanan; G R Martin
Journal:  Arch Biochem Biophys       Date:  1972-03       Impact factor: 4.013

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 6.  Urinary excretion of hydroxyproline in health and disease.

Authors:  K I Kivirikko
Journal:  Int Rev Connect Tissue Res       Date:  1970

7.  Collagen metabolism of the skin in Marfan's syndrome.

Authors:  O Laitinen; J Uitto; M Iivanainen; M Hannuksela; K I Kivirikko
Journal:  Clin Chim Acta       Date:  1968-09       Impact factor: 3.786

8.  The cross-linking of collagen and elastin: enzymatic conversion of lysine in peptide linkage to alpha-aminoadipic-delta-semialdehyde (allysine) by an extract from bone.

Authors:  S R Pinnell; G R Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1968-10       Impact factor: 11.205

9.  Tropoelastin purification: improvements using enzyme inhibitors.

Authors:  L B Sandberg; E Bruenger; E G Cleary
Journal:  Anal Biochem       Date:  1975-03       Impact factor: 3.365

10.  Study of fibroblasts in Marfan's syndrome.

Authors:  M Macek; J Hurych; M Chvapil; V Kadlecová
Journal:  Humangenetik       Date:  1966
View more
  17 in total

1.  Marfan syndrome is closely linked to a marker on chromosome 15q1.5----q2.1.

Authors:  P Tsipouras; M Sarfarazi; A Devi; B Weiffenbach; M Boxer
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

2.  Doxorubicin-induced inhibition of prolyl hydroxylation during collagen biosynthesis in human skin fibroblast cultures. Relevance to imparied wound healing.

Authors:  T Sasaki; K C Holeyfield; J Uitto
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

3.  Functional role of periostin in development and wound repair: implications for connective tissue disease.

Authors:  Douglas W Hamilton
Journal:  J Cell Commun Signal       Date:  2008-07-20       Impact factor: 5.782

4.  Marfan syndrome: no evidence for heterogeneity in different populations, and more precise mapping of the gene.

Authors:  K Kainulainen; B Steinmann; F Collins; H C Dietz; C A Francomano; A Child; M W Kilpatrick; D J Brock; M Keston; R E Pyeritz
Journal:  Am J Hum Genet       Date:  1991-09       Impact factor: 11.025

5.  NMR studies of localized water and protein backbone dynamics in mechanically strained elastin.

Authors:  Cheng Sun; Odingo Mitchell; Jiaxin Huang; Gregory S Boutis
Journal:  J Phys Chem B       Date:  2011-11-07       Impact factor: 2.991

6.  Marfan syndrome: light at the end of the tunnel?

Authors:  P Tsipouras
Journal:  Am J Hum Genet       Date:  1990-04       Impact factor: 11.025

Review 7.  The microfibril hypothesis of glaucoma: implications for treatment of elevated intraocular pressure.

Authors:  John Kuchtey; Rachel W Kuchtey
Journal:  J Ocul Pharmacol Ther       Date:  2014-02-12       Impact factor: 2.671

8.  Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome.

Authors:  Daniel P Judge; Nancy J Biery; Douglas R Keene; Jessica Geubtner; Loretha Myers; David L Huso; Lynn Y Sakai; Harry C Dietz
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

Review 9.  Elastin and collagen fibre microstructure of the human aorta in ageing and disease: a review.

Authors:  Alkiviadis Tsamis; Jeffrey T Krawiec; David A Vorp
Journal:  J R Soc Interface       Date:  2013-03-27       Impact factor: 4.118

10.  The borohydride-reducible compounds of human aortic elastin. Demonstration of a new cyclic amino acid in alkali hydrolysate, and changes with age and in patients with annulo-aortic ectasia including one with Marfan syndrome.

Authors:  T Halme; M Jutila; T Vihersaari; P Oksman; N D Light; R Penttinen
Journal:  Biochem J       Date:  1985-11-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.